Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 7 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

8(100.0%)

8Total

N/A(8)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT05750602Not ApplicableCompleted

Combined Effect of LIMICOL and Physical Activity on LDL Cholesterol and Muscle Function.

Role: lead

NCT01469936Not ApplicableUnknown

Effect of PERMEAPROTECT on the Quality of Life of Patients With Fibromyalgia

Role: lead

NCT01356199Not ApplicableCompleted

Effect of Artronat on the Quality of Life of Patient With Osteoarthritis

Role: lead

NCT01354340Not ApplicableCompleted

Dose Effect of Limicol on (LDL)-Cholesterol Levels

Role: lead

NCT01139398Not ApplicableCompleted

Effect of Limicol on (LDL)-Cholesterol Levels in Moderate Hypercholesterolaemia

Role: lead

NCT01353872Not ApplicableCompleted

Nutrition Effects on Fatigue During Tennis Playing

Role: lead

NCT01354327Not ApplicableCompleted

Effects of Limicol on LDL-cholesterol

Role: lead

NCT00799630Not ApplicableCompleted

Effects of Nutraperf Consumption in Runners

Role: lead

All 8 trials loaded